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Abstract 
Piezo proteins are transmembrane ion channels, specialized in detecting mechanosensitive 
stimuli and transduce mechanical forces into biochemical signals. Piezo proteins research has 
helped understand physiological mechanisms, but the integrative role that Piezo1 plays in the 
regulation of the microvasculature has remained unstudied. Our main objective was to 
characterize ex vivo microvascular responses to the blockade of Piezo1 mechanotransduction 
in male (n=29) and female (n=24) Sprague-Dawley (SD) rats. Gracilis arterioles (GA) and 
middle cerebral arterioles (MCA) were harvested for ex-vivo vessel preparations. After 
vessel viability confirmation, every vessel was submitted to myogenic and flow challenges 
under control conditions and after Grammostola Mechanotoxin 4 (GsMTx4) incubation to 
blocking Piezo1 channels, to quantify the homeostatic response of arterioles before and after 
Piezo1 antagonism. We are able to report Piezo1 as indispensable component in vascular 
smooth muscle cells (VSMC) and Endothelial cells (EC) to sense and change vessel diameter 
based on intravascular pressure and shear stress, correspondingly. Also, we report for the first 
time a heterogeneous response in males and females after Piezo1 antagonism in 
representative resistance arterioles from the skeletal muscle and cerebral circulation.   
 
 
Keywords 
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Homeostasis, Myogenic response, Shear-induced dilation, Gender dimorphisms. 
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Summary (Lay Audience) 
Piezo proteins are found in cell’s membranes and specialize in detecting mechanical forces 
(e.g. friction and pressure) and translating this information into signals that promote proper 
cellular function.  To date, the study of Piezo proteins has helped understand diverse cellular 
mechanisms and their importance in the context of heart and blood vessel diseases. 
Nevertheless, Piezo1’s role in the regulation of the smallest vessels in the body and how 
Piezo 1 function may vary between males and females, has remained unstudied. We focused 
on blood vessels from the skeletal muscle and cerebral circulations, due to their natural 
differences in regulating blood flow. The main objective of our project was to understand 
Piezo 1’s role in their unique regulation properties and if the negative effects of Piezo 1 
dysfunction impact differently on males and females. By approaching our project 
contemplating sex and anatomical differences, we have opened up the field to using Piezo1 
as a potential target for therapies to provide more effective treatments for cardiovascular 
diseases in males and females.  
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Chapter 1  
 
Introduction to Microcirculation and Piezo Proteins 
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1.1 Introduction & Background 
The principal objective of this chapter is to give the reader an overall perspective on the 
importance, function, and regulation of the microcirculation. We will also describe the 
anatomic components of the microvasculature and review the concepts of shear stress-
mediated dilation and myogenic constriction, in order to underscore the important role 
these physiological mechanisms play in maintaining homeostasis in the microvasculature. 
Additionally, our aim will be to update the reader on gender-based dimorphisms in 
vascular regulation. Finally, we will describe the physiological properties associated with 
mechanosensitive proteins, elucidate how Piezo1 enables endothelial cells (EC) and 
vascular smooth muscle cells (VSMC) to sense forces that eventually will be transduced 
into electrochemical signals and initiate shear stress- and myogenic-dependent vessel 
control. 
1.1.1 Overview of the microcirculation & homeostasis (control & 
regulation) 
The cardiovascular system is composed of the heart and an extensive system of blood 
vessels serving as an interconnected organic unit to efficiently transport blood to all body 
tissues. In the context of Walter Cannon's concept of homeostasis, described it as the 
ability of the organism to maintain a stable internal environment, the cardiovascular 
system supplies a continuous blood volume to tissues/organs during physiological 
conditions, physiological stress (e.g. exercise, emotional stress) and pathological 
conditions. In order to maintain such a stable internal environment in tissues, the 
vasculature is under continuous modulation of pressure and flow through changes in 
lumen dimensions and by redistribution of circulation through vascular beds in accord 
with the changing metabolic needs of specific tissues and body activity.  It is the result of 
this balancing mechanism, along with a plethora of mediator pathways, that the 
functional cellular elements in tissues can satisfy their metabolic needs in a specialized 
manner (12–14). 
Each of the components comprising the cardiovascular system contributes essentially to 
the maintenance of homeostasis (14,15). In order to achieve a balanced tissue 
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environment, blood has to be made available to the various organs of the body through 
the pumping action of the heart and distributed by way of large vessels and a succession 
of arterial branches of diminishing caliber. Nevertheless, the basic element of vascular 
homeostasis occurs within the microcirculation (arterioles, capillaries, and venules) by 
adjusting the surface area available for metabolic exchange and maintaining exchange 
between blood and the parenchyma at a prescribed level (13,16). Although definitions 
and borderline diameters for macro- and micro-circulation can vary, it is widely accepted 
that diameters from smaller microvascular components remain consistent regardless of 
mammalian species (12,14,17,18). Moreover, recognition of microvascular architectural 
and functional similarities between species has blossomed into a rich area of investigation 
that has shaped our understanding of the biochemistry and cell signaling pathways 
influenced by pressure and flow sensors (16,19–21). 
With progressive diminishing diameter in the successive vascular branches of every 
network, maintenance of structural integrity and efficient exchange comes with 
physiological challenges to maintain adequate arteriolar tone and normalize the effects of 
acute and chronic pressure and flow disturbances. Some of the controls that acutely 
modulate lumen dimensions and flow redistribution among the vascular bed include the 
sympathetic nervous system, baroreflex mechanisms, metabolic feedback, shear stress-
induced vasodilation and myogenic constriction (18,20). However, to obtain vascular 
homeostasis under conditions where persistent perturbations in pressure-flow 
relationships develop, arteries present dramatic changes in composition, structure, and 
function; a fundamental and often ignored characteristic of arteries to maintain their 
composition, geometry, and function over long periods despite the variable changes in 
mechanical loading (18,22). 
Though, is clear that a myriad of mediator pathways are implicated in vascular 
adjustments needed to achieve vascular homeostasis, our efforts will be focused on the 
effects that myogenic control and shear stress dilation have over the modulation and 
control of perfusion within the microcirculation. The microcirculation's role in vascular 
homeostasis essentially depends on multiple specialized molecules in cells transducing 
superficial stresses near the vessel walls that result from the hemodynamic conditions 
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inside blood vessels (20,23–25). Pressure-induced myogenic contraction, intrinsic to 
vascular smooth muscle cells, and the vasorelaxing influence of endothelial cells via the 
release of vasodilator autacoids in response to shear stress, have been widely described 
since the beginning of the twentieth century, but complete understanding of the effector 
biochemical signals involved in acute and chronic regulation of VSMC & EC cellular 
function and morphology are yet to be defined (26–29). 
The definition of myogenic contraction and endothelial shear-induced dilation, along 
with previous work done to accurately describe these mechanisms, will be described in 
more detail on the next sections. 
1.1.2 Microvascular techniques and advancements 
In 1628 “An Anatomical Exercise on the Motion of the Heart and Blood in Living 
Beings" by William Harvey first established the circulation of the blood and postulate the 
existence of “invisible pores to the flesh” to explain a path for arterial blood flow in 
tissues that connects to the venous counterpart and return to the heart (1–3). Since then, 
subsequent contributions focused on the specialized structure of the microcirculation (2). 
It was not until research by Poiseuille in the 1830s that attention in the field was 
redirected to understanding the hemodynamical properties that rule the microcirculation 
(1).  
Development of ex vivo methods like wire-mounted vessels, and perfused and 
nonperfused isolated microvessel preparations have provided the opportunity to control 
and measure the numerous variables modulating the physiological behavior of resistance 
arterioles. While the physiological behavior is better observed under intact conditions, 
vascular adjustments under these conditions are not easily attributed to specific effector 
mechanisms (4). The importance of cannulated microvessel techniques relies upon their 
flexibility for study, and these have been found to be representative of in vivo 
physiological performance (4). Initially described by Uchida, et al. in 1967 and further 
enhanced by Duling, et al. in 1981, studies in isolated pressurized microvessels (12-112 
m) have provided much of our current understanding of the intrinsic microvascular 
vasomotor response and its underlying mechanisms where the effects of pressure could 
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be clearly distinguished from flow, metabolic, neural, and endothelial influences (5–8). 
Nevertheless, more than a century of research efforts have failed to create consensus with 
regard to the microvascular intracellular signaling pathways that pair supply/demand to 
multi-fold metabolic rate changes and the conversion of mechanical forces into electrical 
responses (mechanosensory transduction) remains a major biological question (4,9,10). 
One of the hypotheses proposed to explain the coupling mechanism is the observation of 
stretch-activated ion channels (SAC) serving as “sensors” of mechanical forces and 
allowing the influx of extracellular calcium, resulting in a vascular tone increase. The 
conundrum that this hypothesis presents comes with the conceptual framework that 
defines SAC's properties. Activation of mechanosensitive channels would elicit calcium 
influx refractory to calcium channel blockers, and the resulting potassium conductance 
increase would hyperpolarize the cell. However as Harder et al. reported, their activation 
comes associated with membrane depolarization, can be blocked by calcium (Ca++) 
blockers and can be up- or down-regulated by potassium channel modulators (agonists 
and antagonists) (11). 
Even though ex-vivo isolated vessel preparations have been groundbreaking, there are 
inherent strengths and limitations to these techniques. When carried out effectively, 
isolated preparations allows precise control of experimental conditions (luminal pressure, 
shear stress, superfusate & perfusate solutions, etc.) while eliminating confounding 
variables such as autonomic innervation, hormonal and metabolic effects (12–14). 
Ironically, the main disadvantages to ex-vivo preparations derive from the loss of the 
neuro-humoral, metabolic and intercellular conduction input (14,15). Additionally, the 
limitation of this preparation to feed arteries and trauma due to the dissection of the 
vessels can also be problematic (14). 
Technological advancements and increased sophistication of in vivo microcirculatory 
techniques including skeletal muscle, cheek pouch and brain preparation, to name a few, 
have made possible a more convenient approach to extrapolate results carried out in 
studies on small mammals (16). It has been mentioned that the main disadvantages to ex-
vivo preparations derive from the loss of the neuro-humoral, metabolic and intercellular 
conduction input (14,15). On the other hand, knowing and quantifying the effect of in 
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vivo physiological disturbances on intact microvascular beds convey definite advantages 
to the interpretation of the true effect of any given agent (e.g. pharmacological or 
experimental agent) (2,16,17). Classical vascular beds, as the skeletal muscle and brain, 
have been employed and defined as representatives of the microcirculation due to their 
interpretative strengths. Skeletal muscle comprises nearly one-half of the body mass and 
has been shown to contain practically every vascular receptor known and studied 
(16,17). However, major limitations from these studies of skeletal muscle arteriolar 
network structure stem from the approach used to collect the geometric and topological 
data, as well as the inherent anatomy of the skeletal muscle preparations and frequently 
used networks(terminal/distal networks) (16). The cranial window in vivo preparation 
provides a considerable amount of data on a relatively large surface area of brain tissue in 
the rat, by means of measurements of the microvasculature (e. g. pial, distal MCA), and 
high correlation with pathological states as cardiovascular disease, as well as aging 
(16,18,19). Nonetheless, its major limitation comes from the technical difficulties 
associated with the technique, although these can usually be prevented by being 
extremely meticulous during the surgical procedures (19). 
1.1.3 Microcirculation: Male & Female differences 
Significant differences in metabolic demand, autonomic innervation, overall higher blood 
pressure in males and higher prevalence and earlier settings of cardiovascular diseases in 
males, have prompted decades of studying the effects in the cardiovascular system of the 
gender-specific sex hormones to elucidate the cardiovascular protective effect found in 
female subjects (20–24). 
Historically, gender-based dimorphisms and the role they play in microvascular 
regulation has been understudied. Most of the previous studies in the field have been 
performed on animals of one sex or the other; whether these decisions have been taken to 
prevent hormonal influences as confounding variables or because intrinsic behavioral 
differences between genders facilitate certain studies, inevitably these single-sex studies 
have impaired our understanding on microvascular regulation and the role gender plays in 
pathological states. (20,25). 
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Byrom’s postulates on the effect of estrogens and progestogens over vasopressin and 
other vasoactive autacoids in 1938, and later work in the field by Lloyd in 1959 to 
explain the heterogeneous response to oxytocin in mesenteric vessels were remarkable 
milestones in vascular research (26,27). Nevertheless, critical new insight into the 
responsiveness to catecholamines on microcirculatory blood vessels came from Dr. 
Burton Altura, who presented firm support on the effect female hormones play in 
terminal arterioles. Until his research, it was generally accepted that microcirculatory 
vessels responsiveness to vasoactive peptides was not influenced by sex (26,27). 
Confirmation of estrogenic receptors in endothelial cells was given by Colburn & 
Buonassisi, who provided understanding of the estrogenic contribution in regulating 
blood supply during cyclical functional variations in the female reproductive system and, 
thus, improve fertilization likelihood (28). Continuous research efforts for over forty 
years have led researchers to suggest estrogenic and other sex hormones exert 
nongenomic rapid effects over vascular reactivity through a variety of mechanisms that 
have not been completely understood.   
One of the more prominent ideas shaping this field has been the role that sex hormones 
play on the cardioprotective effect. Studies have defined the 17-estradiol or 17-
estradiol effect the most; where it has been reported to produce an acute and clinically 
relevant relaxation from females through endothelial nitric oxide synthase (eNOS) 
activation and an increase of nitric oxide (NO) release (29). Nevertheless, since the 
1940's studies on males and the effect of testosterone have also been associated with an 
improvement on certain cardiovascular pathologies (30).  Positive effects over angina 
pectoris symptoms and on exercise-induced myocardial ischemia have been reported by 
Hamm & Walker in '42, Sigler in '43 and Lesser in '46 but have failed to effectively 
conclude on testosterone's benefit in myocardial ischemia and coronary artery disease 
(30). Possible mechanisms discussed for this beneficial effect included an improvement 
of oxygen-carrying capacity of red cells, an increase in blood hemoglobin levels and 
dilatation of the coronary arteries or their collaterals. However, the negative effects of 
testosterone remain controversial (e.g., higher coronary artery disease and hypertension 
prevalence in males) (20,30). Multiple meta-analyses and review studies have not been 
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able to associate testosterone with exacerbating the development of cardiovascular 
diseases; in contrast, low testosterone levels are more a marker of poor health. An 
association has been reported between low testosterone levels and an increased 
cardiovascular disease (CVD) mortality, but still studies have lacked the power to 
demonstrate a relationship with CVD morbidity (20,31,32). Therefore, we will focus our 
attention on more studied gender dimorphism postulates, in particular, estrogenic and 
autonomic innervation. 
1.1.3.1 Estrogenic effect over microvascular regulation 
It has been postulated that the activation of eNOS in endothelial cells by estrogen 
receptors α (ERα) is dependent on the PI3-kinase-Akt pathway or mitogen-activated 
protein (MAP) (20). These two intracellular signal transduction pathways involving the 
nongenomic activation of eNOS have been well documented. However, the specific 
mechanism to which endothelial estrogenic dependent vasodilation is specifically 
achieved remains controversial (20,21). Moreover, it remains uncertain whether the 
nongenomic activation of eNOS by estrogen is dependent or independent of increases in 
intracellular Ca2+ and endothelial intervention.  Collins et al. in ’93 suggested that 17-
estradiol might behave as a Ca2+ channel antagonist, but this postulate was mostly based 
on previous evidence on estrogenic calcium antagonist properties and mainly a 
hypothetical conclusion (33). A year later Salas et al. determined that the relaxation 
evoked by 17-estradiol, with a shared effect by 17-estradiol, of coronary arteries may 
be independent of endothelial modulation. They observed vasorelaxation was present 
under conditions where the production of NO was inhibited or in coronary arteries whose 
endothelium had been removed but still, e-NOS showed calcium-dependent activation 
(20,33,34). Nevertheless, in 1997 Caulin-Glaser’s in-vitro studies concluded that 17-
estradiol’s main effect appeared to be mediated through estrogen receptors activating 
eNOS function and did not elicit any intracellular calcium influx (35). Calcium 
dependence studies showed that calcium-mediated vasorelaxation depended on the NOS 
isoform involved. Both eNOS and iNOS (inducible nitric oxide synthase) have been 
detected in EC under certain conditions, but it is the eNOS isoform that is calcium-
dependent, whereas iNOS is not (36). 
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Although, estrogenic direct calcium antagonistic effects are mainly attributed to elicit 
their effects on VSMC, wherein estrogenic response seems to be independent of 
estrogenic receptors and directly block Ca2+ channels of smooth muscle, decrease Ca2+ 
VSMC sensitivity or even increase calcium efflux (20,37).  The endothelial estrogenic 
effect has been associated with ERα as responsible for the nongenomic activation of 
eNOS; however, a recent study demonstrated that ERβ is also able to stimulate the 
nongenomic activation of eNOS in endothelium caveolae (20). It is worth mentioning 
that both Ca2+ antagonist mechanisms are elicited by activation of membrane adenyl 
cyclase and atrial natriuretic factor-stimulated guanylate cyclase activity (20,29).  
Studies in small mammals have helped researchers to affirm this mechanism may 
contribute significantly to the protective effect of estrogen on the development and 
progression of atherosclerotic disease, in the coronary and other arteries of women. In 
addition, estrogen-mediated activation of eNOS may be of major importance to the 
regulation of uterine and placental blood flow during normal physiological pregnancy 
conditions (38). Further studies on acute eNOS activation by estrogen will continue to 
enhance our understanding of the role of this hormone in vascular biology. 
Nevertheless, the estrogenic and progestin effect over blood flow regulation can explain 
only 50% of microvascular changes. Hormonal interaction with other molecules and 
secondary by-products leaves open the question, whether hormonal heterogenous effects 
over the microcirculation, "single-handedly" can explain premenopausal cardioprotection 
in a female subject. 
1.1.3.2 Autonomic nervous system gender-based dimorphisms 
The autonomic nervous system and its divisions' primary function is to assist 
tissues/organs in maintaining homeostasis. Specifically, the sympathetic division of the 
autonomic system act as an essential modulator of the peripheral circulation and blood 
pressure (39,40). Sure enough, the association between increased sympathetic activity 
and cardiovascular diseases has been reported multiple times in human and animal 
models. 
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In an augmented sympathetic nerve activity state, the cardiovascular system undergoes 
several pathophysiological changes. Cardiac output decreases due to a diminished stroke 
volume and −adrenergic responsiveness, as well as a vascular resistance augmentation 
secondary to vascular hypertrophy.  Alexander V. Ng, et al.  confirmed gender as an 
important determinant effect, for the first time, of augmented efferent sympathetic 
nervous system activity and catecholamines increases in plasma through directly recorded 
sympathetic nerve activity to skeletal muscle (MSNA) (41). Although previous reports 
have effectively associated augmented MSNA to age (42,43), Alexander V. Ng postulate, 
underscored the importance of understanding gender dimorphisms in high sympathetic 
states where these pathophysiological changes contribute to hypertension, ventricular and 
vessel’s media layer hypertrophy among the physiological changes mentioned above and 
to which association to elevated incidences for the plethora of pathologies that comprise 
the CVDs represent the best “target” to which medical treatment is directed in everyday 
practice until present times (41,44,45). Nonetheless, regardless of multiple studies 
correlating increased MSNA to older male and female subjects and males < 50 years,  
human and animal studies have failed to confirm the mechanism to which the individual 
“weight” of gender and age play as significant determinants to explain the augmented 
sympathetic activity in older (≥ 50 years) males and female subjects (42,43,46,47).  
The apparent discrepancies on reports showing inconsistent results over the significant 
effect sex hormones play to determine cardiovascular dimorphisms accentuates the need 
of attention into techniques that allow direct observation at all levels of the arteriolar 
hierarchy in the overall microvascular network, as well as to other cellular mechanisms. 
As reported previously, heterogeneous regulation exists throughout the microcirculation 
(2,3,42). Moreover, this focus has helped clarify regional variations in vascular regulation 
and has provided a rich area of research into other related sympathetic mechanisms and 
receptors involved in gender dimorphisms. For example, concentrations of core vesicles 
containing neuropeptide Y (NPY) are found in greater amounts with decreasing vessel 
size & and exerts a cooperative vasoconstrictive effect with noradrenaline (NA) through 
the respective activation of neuropeptide Y type 1 (Y1R) and adrenergic α1 (α1R) 
receptors. Within this scenario, it is logical to expect its contribution to basal blood 
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pressure regulation but its contribution is still debated (48). However, series of studies by 
De Potter et al. and Jackson et al. presented evidence to support the postulate of NPY as a 
critical regulator of baseline blood pressure (BP), especially in vessels of higher order on 
the overall vascular architecture, where they are chronically mediated by NPY (48–51). 
Series of studies by Jackson et al. focused on gender and estrogen as important 
contributors to NPY modulation in sympathetic activity regulation, in accord with 
previous findings, female reported lower levels of baseline sympathetic activity. Thus, it 
was hypothesized that female subjects would have decreased NPY vascular control. Since 
NPY & NA balanced synergetic input is required for maintenance of vascular tone in 
skeletal muscle (24,41,52,53). Moreover, a novel finding in these studies was that, in 
contrast to males, female rats did not exhibit basal endogenous Y1R control of hindlimb 
vascular conductance (VC) despite the fact of Y1R a bioavailable neuropeptide Y (24). 
The observed differences and the lack of endogenous NPY receptor activation suggested 
that limited bioavailability of NPY. It was later hypothesized by the same group, that 
female rats have augmented proteolytic processing of NPY, augmented autoinhibitory 
Y2R NPY receptor expression, and activation. Nevertheless, the mechanisms to which 
these three elements would limit NPY bioavailability and estrogenic influence over 
neurogenic vasomotor control was not confirmed and the NPY bioavailability 
dimorphism between genders was suspected to be due to estrogen’s impact on NPY 
release and Y1R expression, but not Y2R expression or peptidase activity  (52,54).  
Whether small sample size, the inclusion of subjects taking hormone replacement therapy 
or intrinsic socio-cultural differences in human populations have skewed results in 
studies previously referred. It has not been overlooked the need for larger and 
longitudinal studies in order to accurately establish the effects of gender on sympathetic 
nerve activity and its relationship with CVDs. In regard of this matter, is worth to 
mention that the significance of understanding gender dimorphisms are underscored in 
the conflicting results of two vastly referenced human studies on gender dimorphisms and 
the role sex hormones play in a clinical setting, what has become known as gender-
related cardioprotection, the Heart Estrogen/Progestin Replacement Study (HERS) and 
the Nurses' Health Study. While the HERS demonstrated that hormone therapy did not 
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reduce the risk for cardiac events and even remarks the increase for Coronary Heart 
Disease (CHD) in the first use of the Hormone replacement therapy and a later reduction 
in the fourth and fifth year. Yet, the Nurses' reported an overall reduction in 
cardiovascular events of about 40-60%(20,55,56). The contradictory results reported in 
these two studies exemplify the need to elucidate other factors contributing to sex 
differences in microvascular autoregulating mechanisms since they can potentially bring 
specific target therapies for males and females with CVD’s. Whether by lack of sex-
specific clinical trials or underrepresentation on the ones developing, these and many 
other obstacles contribute to maintaining CVD’s as the leading cause of death for women 
in both industrialized and developing nations (57,58). 
1.1.4 Microcirculation: Differential blood flow control in skeletal 
muscle and cerebral 
A number of mechanisms have been broadly described in multiple physiological and 
medical literature as imperative mechanisms to control local blood flow, some of them 
include autonomic nervous stimuli, myogenic responses, shear-dependent responses, 
metabolic responses, conducted responses propagated along vessels, and communication 
between paired vessels (39,59–61). Manifold studies have described the previously 
mentioned mechanisms and the biological response that effector cells wield in the overall 
circulation. However, special consideration to myogenic control and shear stress-induced 
dilation will be taken, since they will be the focus of the next subsections.   
Both mechanisms exert local regulation of blood flow to organs/tissues and supply 
correspondingly to the metabolic demands. For example; the rate of blood flow in 
skeletal muscle varies directly with the contractile activity and the specific muscle being 
studied. In resting muscle, most of the capillary bed sub-perfused and total blood flow is 
between 1.4 to 4.5 mL/minute/100 g. Nonetheless, during aerobic exercise arterioles and 
small arteries relax and muscle blood flow may increase up to nearly 100-fold (39,61,62). 
Whereas in the brain, blood volume and extravascular fluid must remain relatively 
constant; with any given change in one of these fluid volumes, it must be accompanied by 
a reciprocal change in the other. In human studies, it has been reported that the rate of 
cerebral blood flow is maintained within a narrow range and averages a rate of 55 
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mL/minute/100 g (39). 
With this heterogeneous control of blood flow, an optimized distribution of oxygenated 
blood can be achieved by distributing just at a slightly higher rate to the tissue that needs 
oxygen the most, in order to maintain the metabolic needs of the organ/tissue and, under 
baseline conditions, never experience hypoxia; all of this while maintaining minimum 
workload to the heart. 
Table 1 : Blood to Different Organs and Tissues under basal conditions – Adapted 
from "Table 17-1: Blood Flow to Different Organs and Tissues Under Basal Conditions"; 
Unit IV, Chapter 17, page 192.  from Guyton & Hall Textbook of Medical Physiology 
12th Ed. 
 
It is important to mention the ratio to which both mechanisms produce their effect are 
interchangeable in some tissues. Although, regulation of cerebral blood flow  
(CBF) involves interplay among myogenic, shear stress, metabolic, and neural 
mechanisms (regional neural activity) intracranial arterioles respond immediately to 
changes in cerebral perfusion pressure (39,60,63,64). 
In general, cerebral blood flow is fixed to stringent ranges of intraluminal arterial 
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pressure (60 – 160 mmHg) to prevent pathophysiological states (e.g. ictus, cerebral 
edema). However, reliability on myogenic responsiveness for the autoregulation of CBF 
not only assists on said preventive measurements; but also, the considerably larger 
myogenic tone provides cerebral vessels with an apparently larger capacity to increase 
blood flow depending on neural activity demand (64). This is in accordance to Carlson et 
al. theoretical model, by combining predicted values of the myogenic and metabolic 
responses they were able to produce the strongest autoregulation as observed by 
experimental results; supporting the concept that information about metabolic tissue 
status is communicated to upstream vessels by conducted responses (39,59,61). 
It is important to highlight that while the contribution to local blood flow regulation from 
shear stress and myogenic constriction play an important role as components of the 
circumferential tension exerted inside the vessel walls, they do not represent all known 
mechanisms but do represent individual fractions of the dominant stress to which the 
vasculature is subjected to. Regardless, metabolic variability in demands within different 
tissues/organs may modulate the contributions of response mechanisms to autoregulation 
(59). Therefore, the importance of running comparative studies considering skeletal 
muscle and cerebral vasculature has not passed unattended by our group, expecting 
differential vascular effects, our current project focuses on describing phenotypical 
differences on vasculature derived from both tissues. 
1.2 Myogenic Control 
1.2.1 Concept 
The myogenic effect was first described as the ability of a vessel to vasoconstrict or 
vasodilate when intravascular pressure correspondingly rises or decreases (6,65). It 
pertains to the intrinsic ability of smooth muscle cells in the vessels to modulate their 
tone after an asymmetrical force leads to the deformation of the vascular wall. 
Traditionally, it was assumed that the myogenic response was limited to VSMC 
transduction and independent of any neural or humoral intervention. Nevertheless, in the 
'80s and '90s a series of studies reported the ability of the endothelium to maintain a 
certain degree of control over VSMC tone in response to chemical and physical stimuli 
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(6,20,66). 
Despite a multitude of studies that have brought knowledge to the cellular mechanisms 
involved in the myogenic response, it has been difficult to establish a definitive cause-
effect relationship. But a direct Ca++-dependent initiation of contraction or intracellular 
release of Ca++ stores secondary to unspecific cation influx into the cell seems to be the 
most plausible sequence of events proposed by a series of studies (39,67). 
1.2.2 Previous work 
Historically, characterization and description of the vascular mechanobiological 
properties can be traced to the early twentieth century. In 1902, Bayliss established the 
idea of the myogenic response (6). He considered this response to be independent of 
central nervous system excitation and of myogenic nature, but too rapid to be metabolite 
mediated. Though Bayliss’ observations were groundbreaking, it was not until almost 
fifty years later that Folkow's denervated preparations confirmed VSMCs’ pressure-
dependent capacity to generate active tone (30,31). 
The myogenic tone plays a significant role in various physiological mechanisms, but two 
functions stand out: establishment of basal vascular tone and autoregulation of local 
blood flow and capillary pressure (6). However, the signaling mechanism required for 
VSMC to elicit vasoconstriction after distention of the wall is still not completely 
understood. Yet, it has been proposed and widely accepted that an activation of 
membrane calcium channels in VSMC is secondary to length-dependent activation 
(67,69).  
It is well-known that vascular initial length serves as a modulator for sympathetic 
agonists. Since sympathetic agonists commonly potentiate the myogenic response, it is 
likely that a functional overlap exists for the two pathways (6). Though possible, most 
evidence to support the postulate is indirect and limited. Davies et al. have provided 
experimental evidence supporting this mechanism in isolated vessel experiments, but the 
sites sensitive to distortion or the presence of mechanosensitive ion channels provide 
another alternative for the translation of the distorting force into a biochemical event (67).  
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It was in 1954 when Bulbring’s study in guinea-pig taenia coli first proposed “a close 
correlation between membrane potential, the rate of discharge and tension”; nonetheless,  
it was not until 1969 that Uchida & Bohr presented for the first time the postulate that the 
myogenic response might reflect an improved excitation-contraction coupling resulting 
from membrane depolarization and increased Ca++ permeability (6,70). Even though 
there is a myriad of evidence supporting this postulate, the electromechanical coupling 
cannot fully account for myogenic behavior and other mechanisms must be involved to 
modulate cell depolarization; e.g., changes in Ca++ sensitivity (6). 
Other intracellular mechanisms have been involved in the modulation of VSMC 
depolarization and are discussed in detail in review papers such as Davis & Hill, heavily 
referenced in this subsection (6). Nevertheless, it is important to consider the modulating 
role that estrogen plays in females’ myogenic response. Kaley & Huang, besides their 
detailed review of the estrogenic role in the cardiovascular function, reported results 
obtained in this matter (20). Kaley & Huang concluded estrogen contributes to the 
regulation of peripheral resistance, as a consequence of a complex regulating mechanism. 
Overall, their evidence suggested the estrogenic influence on potentiating the basal 
release of endothelial NO, influencing estrogen receptor activation of the NO/cGMP 
cascade, which attenuates myogenic response, or normalizing altered prostaglandin 
synthesis preventing the production of prostaglandin H2 (PGH2) (20), with similar results 
on female OVX (ovariectomized) and OVX+OVE (estrogen replacement) rats. 
Additionally, the genomic disruption of ERα obliterates the modulation of the myogenic 
response mediated by estrogen. Their series of studies concluded that estrogen regulates 
arteriolar responses to intravascular pressure in both, physiological and pathological 
conditions & intervenes in the modulation of a lower basal tone on female microvessels 
(20). 
1.3 Shear stress/flow-induced dilation 
1.3.1 Concept 
Shear stress-induced dilation is defined as a vasodilation response due to increases in 
wall shear stress (WSS). As blood (a viscous fluid) flows through a vessel, it exerts a 
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force parallel to the vessel wall as a result of the friction between the stationary cell-free 
layer and the layer of blood, immediately below, moving faster in response to the 
pressure gradient. This drag is known as wall shear and, the units of force elicited 
measured in dynes/cm2 (71).  
Equation 1: Shear stress 
τ = 4 ηQ/πr3 
In agreement with the shear stress (τ) formula, increases in flow rate and viscosity are 
directly proportional to increases in wall shear and depends heavily on the integrity from 
the vascular endothelium (20,72,73). In conjunction with exposure of mechanical forces, 
endothelial cells in-vivo, maintain a balance along to chemical stimuli to promote 
transmitting and transducing information from the blood to the rest of the vessel wall. 
These signal transduction mechanisms range from extremely rapid responses like electric 
activation currents through ion channels to relative slow structural changes elicited by 
gene expression regulation. Moreover, endothelial shear sensing is indispensable 
activating many of these responses. Thus, most of them are not fully understood. (74,75)  
A plethora of studies has focused on synthesis and release of vaso-relaxant factors by 
ECs, in order to elucidate some of the mechanisms involved in the shear stress response. 
Prostaglandin I2 (PGI2), Nitric oxide (NO) & Endothelium-dependent hyperpolarizing 
factor (EDHF) have been well described and understood as endothelium-dependent 
mediators, by-products of the shear stress-dependent response (20,39,59,72,76). Although 
the intracellular signaling processes have been extensively studied, the cellular 
mechanism responsible for mechanotransduction of shear stress remains elusive. 
1.3.2 Previous work 
First reports of vasodilation secondary to increases in blood flow are attributed to 
Schretzenmayr; nonetheless, the ability of the vascular endothelium to sense and respond 
to the flow of blood was observed more than a century ago by Rudolf Virchow (77). In 
addition, Shchetzenmayr was able to make a key observation and suggested for the first 
time the relevance of preservation of this mechanism to prevent pathophysiological states 
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(78). The cellular mechanisms by which vessels could exert vasodilation remained 
obscure for 50 years, due to little interest in the matter (79). It was not until the 
development of ex-vivo techniques and the innovative work by Furchgott et al. that 
reports on the role of endothelial cells’ functional contribution to active tone by 
“releasing a substance (or substances) which in turn acts on the smooth muscle cells in 
the media to activate relaxation” was first postulated and posteriorly confirmed  by other 
groups (80,81).   
Arguably, short-term responses to shear stress, like intracellular signaling processes and 
the excretion of flow-mediated humoral agents, have been predominantly the focus of 
studies (68). NO synthesis and its flow-mediated release were suggested by Rubanyi et 
al. in the mid-'80s, although failed to properly characterize the flow-mediated humoral 
factor in question, which they referred to as an endothelium-derived relaxing factor 
(68,76). Through bioassay experiments, they were able to demonstrate, though with 
limitations, that the endothelial-based dilation observed in their ex-vivo preparations was 
due to a non-prostacyclin relaxing mediator that increased its bioavailability after 
superoxide dismutase infusion (76). Until the early 90’s most of the research efforts were 
performed on larger arteries and conduit vessels. Thus, conflicting observations were still 
reported in large vessel preparations, and whether shear stress-mediated dilation was 
observed to be endothelium-dependent or independent depended on the particular 
experimental circumstances (68). Bevan's suggestion on the variability seen, and the 
motive for these difficult to resolve and seemingly conflicting observations, was that 
these issues were due to heterogeneous endothelium effects between large and small 
blood vessels (68). This later was confirmed by multiple studies on modeling techniques 
in skeletal muscle, cardiac muscle and cerebral tissue (17,59,63,75,82–85).  
Nevertheless, research in coronary arteries and coronary beds by Kuo et al. (1990 & 
1992) and Pohl & Busse (1990) reported the preservation of endothelial flow-mediated 
control in resistance arterioles (72,73,81,86–89). Further improvements on isolated vessel 
and in-vivo techniques allowed clarity to elucidate the biochemical cascade involved in 
the flow-dependent response, as shown in Figure 1 (73). The mechanism studied the most 
has been the modulation of vasodilation through NO (72,76,86,87,89). Nitric oxide 
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induces an increase in cellular cGMP (cyclic guanosine monophosphate). The increase of 
cGMP results in the inhibition of agonist-induced phosphatidylinositol hydrolysis, 
stimulation of the plasmalemmal Ca++ pump, as well as augmentation of Ca++ uptake 
into the sarcoplasmic reticulum. Overall, the increase in intracellular calcium efflux and 
activation of Ca++ dependent K+ channels contributes to a hyperpolarizing state of the 
EC. In addition to the reduction of intracellular free Ca++, cGMP may also be involved 
in a reduction of the Ca++ sensitivity of the contractile apparatus by dephosphorylation 
of myosin light chains (92).  
 
Figure 1: Diagram of endothelial functions which directly or indirectly affect 
vascular tone. 
Although a plethora of hypotheses contemplating transduction of the mechanical 
environment to which ECs are exposed has been growing in acceptance, work still has to 
be done to fully understand the mechanobiological mechanisms that influence flow-
induced dilation and local regulation of blood flow. One of the most promising 
mechanisms is the discovery of stretch-activated ion channels (90). Although we will 
discuss this hypothesis further in this chapter, it is significant to mention that ion-specific 
stretch-activated channels are present on endothelial cells, and blocking these channels 
has been shown to inhibit the induction of NO and expression of eNOS and TGFb by 
shear stress (77,90).  
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As mentioned in subsection 1.1.3.1, it is important to consider the modulating role that 
estrogen plays in females' shear stress response. Kaley & Huang's review took into 
consideration the role estrogen plays in the regulation of vascular flow-dependent 
responses (20). They were able to demonstrate an upregulating mechanism of endothelial 
autacoid synthesis (NO, PGs & EDHF) elicited by estrogen that enhanced vascular 
responses to flow, and the magnitude of the dilation to shear stress was significantly 
greater in arterioles of females, but not in males (20). Additionally, they were able to 
confirm this postulate, since OVX female rates had abolished the enhanced NO-mediated 
dilation and were able to revert the obliterated dilator response once estrogen replacement 
was installed, even in OVX+OVE hypertensive rats (20). They concluded that the 
estrogen-dependent vasodilator response is caused by transcriptional upregulation of 
eNOS by estrogen (confirmed in cell cultures of pulmonary artery endothelial cells), 
modulated by Ca++ dependent modulation of eNOS. Additionally, Huang & Kaley were 
able to reveal a novel mechanism, by which EDHF contributes to the maintenance of 
shear stress-sensitive regulation, particularly in female rats in deficient NO synthesis 
states, suggesting that EDHF synthesis is a back-up mechanism to maintain flow-induced 
dilation in pathological conditions (20). 
We have commented previously that the understanding of shear stress-dependent 
vasodilation response has focused its attention on short-term responses elicited by 
neurohumoral mediators or force mechanotransduction interacting with ECs, glycocalyx 
& endothelial surface layer (75,90). Nevertheless, a couple of reviews have stressed the 
importance of blood flow in modulating not only local vasodilation but also to long-term 
effects that regulate local adaptative structural changes, influencing vessel size, diameter 
and length (68,77,91). These structural changes include damage and repair near branch 
points and bifurcations, and chronic vessel wall changes that appear to be evoked by 
transcriptional changes mediated via shear stress responsive promoter elements (SSREs) 
that bind transcription factors, which are also activated by shear stress (73,77,90). 
Activation of endothelial stimulus-response coupling to shear-stress comes at the expense 
of a fine-tuned balance between intravascular pressure and shear stress sensing by the 
endothelium, to which Secomb & Pries defines as a pressure-shear hypothesis (92). 
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Overall the pressure-shear hypothesis estates that vascular equilibrium is given by a 
characteristic relation between wall shear stress and pressure that would trigger short- or 
long-term structural adaptations to the vessel (92).  
Due to intrinsic variations in the design of vascular networks between different tissues 
and natural diameter decreases in the vascular components of the microcirculation, shear 
stress values cannot be assumed to elicit the same responses to same shear-stress 
stimulus, as Chilian et al. reported in vessels from 25 – 130 m from the coronary 
microcirculation (93). Nevertheless, as reported by Kaley G. et al. in cremasteric 
arterioles & further explored by Secomb et al. using the same experimental shear stress 
and a representative segment model study on vessels ranging from 40 to 300 m,  
maximal sensitivity to wall shear stress occurs in the physiologically relevant range of 10 
to 50 dyne/cm2 (82,94) and in the presence of intact endothelium wall shear stress remain 
relatively constant and supports the postulate that wall shear stress is a controlled 
parameter in vascular networks.  For example, as reported by Kaley & Koller in 
cremasteric arterioles the presence of endothelium mean control wall shear stress was 
26.58 dyne/cm2, within physiological values as reported by other groups (95,96). In 
Long-Evans male rats harvested middle cerebral & penetrating arterioles reported wall 
shear stress values between 11 to 60 dyne/cm2 during physiological conditions (97). In 
rabbit mesenteric arterioles (17-32 m) Tangelder et al. reported that the range of wall 
shear stress was 4.72 to 41.72 dyne/cm2 (98) and in rat cremaster muscle preparation, 
Mayrovitz & Roy observed a reasonably constant wall shear rate (mean 42.53 dyne/cm2) 
in vessels ranging from 6 to 108 m in diameter (96). Similarly, in pial arterioles (35.4 - 
177.8 m), a constant wall shear stress (range 26.95-29.15 dyn/cm2) was found (99).  
However, during stenotic conditions shear stresses can reach levels above several 
hundred dynes per square centimeter (30.4-380 dyne/cm2) promoting platelet 
aggregation, similar to the effect present in a region of endothelial cell desquamation 
after atherosclerotic plaque rupture (100). Higher shear-stress values have been reported 
in Gracilis arterioles of Spontaneously hypertensive rats cannot maintain constant shear 
stress during increases in flow rate; hence, shear stress reaches a much higher value (90 
dyne/cm2) (101). In the late 90’s clinical data confirmed that the initial phase of severe 
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sepsis or septic shock is characterized by low pressure and low systemic flow, therefore 
reduced shear stress (102). As reported by Nohé et al., flow conditions in systemic hyper-
inflammation states, impaired chemotaxis, and decreased leukocyte recruitment persist 
despite persistent upregulation of leukocyte integrins (102). Contrary to what was 
hypothesized before, cell adhesion to surfaces or other cells varies inversely with the 
magnitude of applied shear forces. Cell detachment or failure to adhere may be due to 
either mechanical disruption of existing molecular bonds or the limited time allowed for 
bonds to form between membranes and surfaces (103). Hence, low shear stress promotes 
a deregulated and paradoxical maldistribution of activated leukocytes during sepsis. 
1.4 Piezo proteins: Discovery, properties, pathophysiology 
Briefly discussed in the previous section, mechanobiology concepts and 
mechanotransduction modulated cell activity has been growing into acceptance as 
emerging theories of how mechanical forces affect the cells. Mechanical forces are 
detected by specialized molecules in cells and transduced into electrochemical signals 
that modify acute and chronic regulation of cellular function and morphology. For 
example, it has been well documented that force-induced strains on the cellular plasma 
membrane, on nearly all cell types, are able to alter gene expression by activation of 
secondary chemical pathways or through the cytoskeleton transcriptional activators and 
repressors (77,90,104). One of the most promising theories is the discovery of stretch-
activated ion channels, eliciting sensor-like effects (90,104). Recently, we have been 
seeking to understand how the various “sensors” in the microcirculation integrate to 
optimize energy transfer and blood flow efficiency across intact microvascular networks.  
1.4.1 Discovery & distribution 
Mechanically activated ion channels form pores in the plasma membrane with increasing 
mechanical stimuli. When open, a membrane current is generated by the passive diffusion 
of charged ions down their electrochemical gradient (105). Although most channels 
exhibit selectivity for specific ions, there are also non-selective  cation channels that pass 
a combination of cations (Na+, Ca++, K+), modulated by the inner pore lining of the ion 
channels which determines the ion selectivity and flux of the permeating cations (104). 
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The existence of ion channels that are activated by mechanical inputs was first proposed 
by Bernard Katz in 1950 and several years later reiterated by Georg von Békésy (105). 
Nonetheless, one of the most exciting developments in this area has been the 
identification of Piezo (FAM38a) mechanosensitive proteins (9,15,105). The 
identification of Piezo proteins has been attributed to Coste et al. the identification of 
Piezo proteins (9,105–108). Having identified a cell line that produced robust 
mechanically-induced currents (Neuro2A), they generated multiple silencing RNAs for 
each gene, introduced them to each cell and tested for electrical current attenuation. As a 
result, the Fam38a gene sequence was identified and later renamed as Piezo1. However, 
Coste et al. isolated a second Piezo channel after observing that Piezo 1 was scarcely 
expressed in dorsal root ganglion neurons (DRG). Indeed, Fam38B, posteriorly named 
Piezo2, are closely related to Fam38A and were initially identified and cloned from DRG 
neurons & lung (9,107,108). 
Piezo ion channels have been classified into two isoforms: Piezo1 and Piezo2. Both are 
considered inherently mechanosensitive (105). Piezo proteins have been heterogeneously 
found in multiple tissues across the body (9,108,109). Nevertheless, there is a perceivable 
relationship between the prevalence in the expression of a certain subtype of Piezo 
receptors and the tissue/cell type (109). This could be interpreted as a “tailored” presence 
of Piezo proteins that modulate mechanical transduction depending on the specialization 
on any given tissue/cell where they are found. For example, Piezo1 proteins are primarily 
expressed in non-sensory tissues exposed to fluid pressure and flow (e.g., kidneys, red 
blood cells smooth muscle cells & endothelial cells) (109–113), whereas Piezo2 proteins 
are predominantly found in sensory tissues (e. g., DRG, and Merkel cells) (9,109).  
 
Figure 2: Piezo 1 structure obtained by cryo-electron microscopy (cryo-EM). 
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Furthermore, as reported in recent studies by Liedtke et al., a synergistic role between 
both Piezo channels in tissues (chondrocytes) exposed to high-strain mechanical forces 
was suggested in order to modulate mechanical loads. Although the Piezo1/2 distinct 
distribution pattern is apparently conserved in other species, further studies are needed, 
and extrapolation of Liedtke et al. results cannot be assumed in other tissues since the 
expression of isolated isoforms has also been reported by Patapoutian et al. (114,115). 
1.4.2 Mechanosensation & Transduction (Activation) 
Mechanotransduction is a sensing mechanism conserved through evolution involving 
mechanosensitive ion channels, highly sensitive molecules coupled as clusters in the 
cell's membrane and specialized in conferring force sensitivity (9,108,116,117). In order 
for Piezo channels, like other mechanosensitive ion channels (MS), to transduce the 
transmitted force into electrochemical signals, two mechanisms have been hypothesized: 
1) ‘Force-from-lipids' model, where the stimuli are transmitted directly to MS channels 
via deformation of the bi-lipid membrane, and 2) ‘Force-from-filaments’ model, where 
the interaction between the MS channel and the extracellular matrix (ECM) or 
cytoskeletal proteins are elicited by tethering and resulting in gating of the channel 
(114,118). 
Recent evidence that Piezo1 is gated, at least in part, by direct membrane tension (‘force-
from- lipids’ principle) strongly negates the reliance of gating on structural scaffold 
proteins and confirms the evolutionary conservation of this gating mechanism (105). 
Mechanical perturbation of reconstituted mouse Piezo1 protein in droplet interface 
bilayers (containing no other cellular components) opens Piezo1 with an estimated force 
of 3.4 mN/m, and even lateral membrane tension as low as 1.4 mN/m activates the 
channel in cellular membranes (119). Nevertheless, Patapoutian et al., Grandl et al., and 
Pathak et al. provided confirmation that mechanical indentation of the apical cell surface 
with a blunt glass probe or the application of suction (negative pressure) to a membrane 
patch results in stretching of the membrane, and both manipulations activate Piezo 
proteins (104,107,114,120). Such global or localized stretching of the cell membrane 
argues in favor of the ‘force-from-filaments’ principle and similar mechanisms are 
associated with somatosensory nerve endings in the skin, as well as blood flow-mediated 
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forces by endothelial cells within arteries and veins (111,121).  
Despite conflicting results in support of either principle, a unifying mechanism has been 
proposed by Martinac et al. (112), where the lipid bilayer is sufficient to mechanically 
gate Piezo channels but its fine-tune properties depend on scaffold proteins. Though 
unequivocal evidence on the gating mechanism still awaits, research efforts will continue 
to be made in order to elucidate this and other mechanobiology questions. 
1.4.3 Phenotypes 
Studies in humans and small mammals have identified Piezo 1/2 loss-of- and gain-of-
function phenotypes associated with multiple congenital diseases. In human phenotypes, 
Piezo 1/2 loss-of-function is associated with less severe conditions, compared to those in 
animal models. In knockout mice, biallelic deletions of Piezo 1/2 have resulted in 
embryonic (111) or perinatal lethal conditions (122). 
Loss-of-function Piezo1 phenotypes in humans have been associated to congenital 
lymphatic dysplasia, a pathological state where lymphatic vessels fail to constrict and 
drain from the extracellular space leading to lymphedema, while gain-of-function Piezo 1 
phenotypes are related to autosomal hereditary xerocytosis, a hereditary hemolytic 
anemia characterized by a gradient shift where intracellular K+ content is decreased and 
intracellular Na+ increased, resulting in cation leak across the membrane and erythrocyte 
dehydration (123). A more detailed review of the human loss-of- and gain-of-function 
phenotypes mentioned can be found on Alpert et al. review on diseases of Piezo channel 
mutations, and we refer the reader to this work for better understanding of the gene 
families associated with these pathological states.  
Although, the reported effects of loss-of-function Piezo 1 phenotypes from animal 
models shall be further studied and extrapolation on human phenotype findings must be 
measuredly considered, results reported by Ranade et al. (human HUVEC cells) and Li et 
al. (mouse endothelial cells) are in line with the known contribution by ECs in 
atherogenesis and vascular architecture orientation (111,117,122,123). As a result of 
“sensing” shear stress, Piezo1 contributes to normal cellular and stress fiber alignment 
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along the axis of the shear vector (123). Also, reports from studies carried out to elucidate 
Piezo1 phenotype in erythrocytes were consistent with the human loss-of-function 
phenotype fount in red blood cells of most patients with generalized lymphoid dysplasia 
(123). 
As mentioned, the extrapolation of the results and associations to Piezo 1 phenotypes in 
human pathology must be done carefully. Nonetheless continuous research efforts to 
understand Piezo 1 phenotypical variations in healthy and pathological states are 
continuously being made and should bring into fruition understanding on Piezo 1 proteins 
mutations as a risk variant on diploid and haploid associated disorders. An example of 
this is The Exome Aggregation Consortium (ExAC) database, a database of large-scale 
sequencing projects, as part of various disease-specific and population genetic studies.  
1.4.4 Role in cardiovascular pathological conditions 
A series of studies on Piezo1 have been capable to associate Fam38a with 
pathophysiological conditions such as hypertension (9,111), promoting inward eutrophic 
remodeling due to altered fiber organization, or an increase in intracellular calcium by 
malfunction of the actin cytoskeleton. We have already discussed in previous sections the 
importance of Piezo1 as a determinant of vascular structure in both development and 
architectural remodeling (111,117,122,123). As Retailleau et al. reported, Piezo1 in 
smooth muscle cells is associated with structural changes in the myocytes by eliciting a 
trophic effect during hypertension. Also, without the protective effect of the cytoskeletal 
protein filamin A, a protein that cross-links actin into either networks or stress fibers,  
and increase of Piezo1 gating, arteriolar smooth muscle cell remodeling occurs 
influencing arterial wall thickness without the need of a hypertensive state (107,117–
119). Moreover, the role of Filamin A mutations extends into other pathophysiological 
processes, as they have been associated with a propensity for aortic dilatation, aneurysms, 
abnormalities of the microcirculation, and premature stroke as complications from 
perinodular heterotopia (111,124–126). 
In a series of studies performed by Dr. Kaufman et al. on a femoral ligated rat model, 
they reported that after Piezo1 blocking an immediate reduction to exercise pressor reflex 
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was elicited (112,113). The mechanically sensitive component of the reflex plays a role 
in the increase of sympathetic nervous activity (SNA), blood pressure (BP), heart rate 
(HR), myocardial contractility, and peripheral vasoconstriction, an elemental function for 
adaptation whilst performing intense physical activity (127). Also, exercise pressor reflex 
provides an indirect perspective on peak workload placed on the heart, as well as 
workload placed on the heart throughout the contraction period (113). Secondary to an 
exaggerated sensitization of the mechanical component of the exercise pressor reflex 
(128,129). Persistence of the exaggerated sensitization state of the exercise pressor reflex 
has been previously associated with abnormal hemodynamic responses that contribute to 
the development of Heart Failure & Peripheral Vascular Disease (113,129,130). 
Elucidating the contribution of Piezo 1 modulating the mechanosensitive component of 
these mechanisms may serve as a novel target in the treatment for adverse cardiovascular 
events such as myocardial ischemia or infarction, cardiac arrest, and stroke (131–133).  
1.4.5 Integration of forces 
Piezo1 co-expression in mammalian vascular smooth muscle cells (VSMC) and 
endothelial cells (EC) (127,134) supports the postulate that pressure and shear sensing, in 
arterioles, occurs concurrently and by the same sensor. In the endothelium, Li et al. 
reported dependence on Piezo1 activity of shear stress sensing in the endothelium, 
resulting in a suppressed shear stress-induced Ca++ influx and altered sensitivity due to 
altered fiber and cell organization after Piezo1 depletion or specific inhibition with 
Grammostola Mechanotoxin #4 (GSM) (111,117). Furthermore, they reported a total 
reduction in eNOS and eNOS (serine 1177), results which were later confirmed by Wang 
et al. and Baptiste et al. (111,117,127,134). Wang suggested the reduction of NO 
synthesis was due to an ATP reduction dependent on Piezo1 in endothelial cells. 
However, the mechanism underlying the release of ATP from endothelial cells is still 
poorly understood (134). 
Moreover, Retailleau et al. work reported the influence of Piezo1 on smooth muscle cells 
and how Piezo1 elicits arterial remodeling. However, he failed to report any effect on 
myogenic response in spite of demonstrating that stretch-activated channel (SAC) activity 
in caudal arteries was critically dependent on Piezo1 function and that SACs have been 
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referenced in multiple studies as required for triggering a myogenic response (6,111,135). 
In a smooth muscle cell Piezo1 conditional knockout mouse model, Retailleau et al. were 
able to demonstrate increased Piezo1-mediated structural remodeling in SMC, either by 
mechanical stress or removing Filamin A (FlnA), and it was associated with structural 
defects and remodeling of caudal artery even in the absence of induced hypertension. 
Furthermore, the Piezo1-mediated rise in Ca++ is correlated with greater activity of 
transglutaminases, a cross-linking enzyme in small artery remodeling. Interestingly, the 
removal of a single Piezo1 allele was sufficient to prevent remodeling (9,111).  
Regardless of research efforts in the last 9 years, the mechanisms of the regulation 
(myogenic control and flow-induced dilation) and the chemical cascade upregulated by 
Piezo activation is still understudied. Additionally, gender dimorphisms on Piezo1-
mediated shear and pressure sensing are still unknown. Thus, the focus of our current 
project is to determine gender dimorphisms in shear stress and myogenic control and the 
role Piezo1 plays on local blood flow regulating mechanisms. 
1.5 Purpose 
As we have discussed in this first chapter, understanding the setup, biomechanical 
properties and local regulating mechanisms of the microvasculature are of great relevance 
to elucidate the implications of cardiovascular diseases, still considered, the biggest killer 
worldwide. Cardiovascular diseases comprise 31% of all deaths each year worldwide and 
just in Canada are the cause of 25% of the premature deaths in males and 15% in females 
aged 30-60 years (136). Treatment for all the individual ailments that constitute CVD's, 
by most part change the natural history of the pathology and their goals are focused on 
improving survival rates and reducing morbidity. Nevertheless, CVD treatment that 
statistically reduces mortality still remains challenging, due to the heterogeneous 
pathophysiological mechanisms. 
By far, intracellular signaling processes have been the most extensively studied and have 
been the focus of the current pharmacopeia and treatment therapy options available in the 
present day. Nevertheless, the cellular mechanism responsible for mechanotransduction 
of the myogenic and shear stress responses remains elusive. Thus, our project bears 
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importance on understanding mechanotransduction signals that Piezo1 proteins elicit, in 
an attempt to provide new therapeutic targets or diagnostic efforts to improve CVD 
mortality and morbidity statistics in males and females. 
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Chapter 2  
 
Piezo 1: A fundamental piece to transduce shear and 
circumferential stress in the microcirculation 
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2.1 Introduction 
Bayliss’s description attributing the phenomena of myogenic response to intrinsic 
regulation properties of the blood vessels without any input of the central nervous system 
was the first description of mechanoreception properties attributed to blood vessels (1). 
Mechanoreception is the most widely distributed sensory modality providing the ability 
to sense and adapt to mechanical stress in the environment. Its contribution has been 
associated with evolutionary needs from our prokaryotic ancestors reducing osmotic 
stress and to proprioception, touch, hearing, etc. on more complex organisms comprised 
by a homeostatic relationship of eukaryotic cell complexes (2–4). 
Transmembrane proteins, referred to as mechanical sensitive ion channels (MSCs), are 
responsible to convert said mechanical stresses into electro-chemical signals according to 
the cellular needs. In eukaryotic cells research efforts on MCSs has focused on the TRP 
family; although data suggests involvement in said sensory modality, their role in 
mechanotransduction has never been established and doesn’t fulfill all the criteria for 
transferable mechanical properties (3,4). Therefore, other candidates have been described 
as better representatives of cells mechanosensitive properties; Potassium selective 
channels (K2p) family as TREK-1, TRAAK or NOMPC from the TRP family, to name 
some, have been confirmed to be activated by a number of different mechanical stimuli 
and fulfill the criteria described by Árnadottir et al. and Christensen et al. (4,5) 
One of the major advancements in this area of research has been the discovery and 
description of Piezo proteins by Coste et al. (3,6,7). Piezo proteins are bona fide 
mechanical channels named after the Greek word πίεση (píesi̱) meaning pressure, from 
which two isoforms have been identified (Piezo 1 & Piezo 2) and deemed essential 
components of mechanically activated channels since they fulfill many requirements of 
the criteria for true mechanically activated ion channels, as they are pore-forming 
subunits, confer mechanically activated currents in a heterologous system and are 
necessary components for cell’s mechanical responses in many cellular lines. (7–10). A 
particularity of Piezo proteins that confer great importance in the overall transduction of 
mechanical sensitization of cells is that they represent two of the human proteins that are 
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predicted to have the highest number of transmembrane segments (8). Thus, probably 
contributing more to the detection of mechanical forces compared to other known ion 
channels through its unique structure and associated molecules in the overall cell’s 
architecture (8,11). 
As previously mentioned, Piezo1 proteins are essential components in the cellular 
membrane contributing to the mechanical sensitization transduction in ECs & 
VSMCs.  Li et al. reported endothelial cells’ dependence on Piezo1 to sense shear stress 
and flow sensitivity, a result of altered fiber and cell organization after Piezo 1 inhibition 
with GSM (12). Moreover, Retailleau et al. reported the secondary effect of Piezo1 
inhibition on smooth muscle cells altering arterial remodeling (7). Although Piezo 1 role 
played in flow-induced dilation and the myogenic response has not been properly 
clarified, its co-expression in mammalian vascular smooth muscle cells (VSMC) and 
endothelial cells (EC) (13,14), supports the postulate that pressure and shear sensing, in 
arterioles, occurs concurrently and by the same sensor.  
Over the last year, the purpose of our work was to ultimately understand how Piezo1 
proteins serve in the integration of mechanical forces that elicit opposite responses, 
myogenic constriction in response to increases of intraluminal pressure and flow-induced 
dilation in response to increased shear stress, as well as their role in optimization of 
energy transfer and blood flow efficiency. Besides, to understand Piezo 1 role in the 
regulating mechanisms, the main objective in our current project focused on determining 
gender dimorphisms in shear stress and myogenic control in two different vascular 
locations, cerebral and musculoskeletal vascular networks. As referenced previously, 
metabolic variability in demands within different tissues/organs may modulate the 
contributions of response mechanisms to autoregulation (15). Thus, it is important to run 
comparative studies between skeletal muscle and cerebral vasculature since it is logical to 
expect differential vascular effects.  Our overall hypothesis is that Piezo1 is a 
fundamental component in EC’s and VSMC’s from resistance arterioles to optimize 
rheological efficiency and blood flow distribution via shear and circumferential-stress 
sensing.  
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2.2 Methodology 
2.2.1  Experimental Data Acquisition 
Sprague Dawley rats Males n= 29 & Females n= 25 (~10 weeks of age; M= 414 mg, F= 
264 mg) all protocols received prior approval from the Council on Animal Care at the 
Western University. All rats received an anesthetic compound solution of α-chloralose 
(160 mg/kg) and urethane (1000 mg/kg) via IP injection. 
Table 2: Gracilis & middle cerebral arterioles. Data presented as mean ±SEM 
 Males Females 
Mean SD SEM Mean SD SEM 
Gracilis 
arteriole 
(GA) 
113.05 18.88 4.22 116.00 19.23 5.55 
Middle 
cerebral 
arteriole 
(MCA) 
134.70 22.50 5.03 140.70 13.42 4.25 
After adequate induction of anesthesia Gracilis (GA) and middle cerebral arterioles 
(MCA), were harvested and hung on both sides to glass pipettes in ex vivo single vessel 
heated chamber bathed in physiological HEPES buffer solution. Posteriorly, single vessel 
chambers were connected to a set-up of peristaltic pumps to regulate flow rates and 
intraluminal pressure changes (Living Systems Instrumentation LLC., Fairfax, Vermont, 
USA) and equilibrated for 30 minutes with an open flow. Following, vessels were 
pressurized at 80% of MAP for another 30 minutes until they spontaneously developed 
active tone. Confirmation of vessel viability was carried after spontaneous vascular tone 
development through increasing concentrations of vasoconstrictors and dilators peptides; 
serotonin (5-HT) and acetylcholine (Ach) for middle cerebral arterioles, and 
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Phenylephrine (Pe) and Acetylcholine (Ach) for Gracilis arterioles (Fig1). After 
corresponding drug response curves and viability test confirmed proper function of 
VSMCs and ECs, vessels were exposed to randomized pressure challenges going from 5 
to 160 mmHg, at 20 mmHg incremental intervals; and Flow challenges selecting 5 l/min 
(4.9 dyne/cm2 in GA’s & 2.9 dyne/cm2 in MCA’s), 10 l/min (9.8 dyne/cm2 in GA’s & 
5.9 dyne/cm2 in MCA’s), 30 l/min (29.3 dyne/cm2 in GA’s & 17.6 dyne/cm2 in MCA’s) 
& 60 l/min (58.6 dyne/cm2 in GA’s & 35.13 dyne/cm2 in MCA’s). Shear stress was 
calculated employing of Equation 1 (Ch 1, Sec 1.3.1), where Q was the perfusate flow 
rate and viscosity for HEPES buffer =.83 (20) and was decided to be the only buffer 
utilized for this protocol. Furthermore, it is important to differentiate flow rate vs. shear 
stress since same flow rates can result in heterogeneous shear stress values depending on 
the design of vascular networks between different tissues, hierarchical diameter decreases 
in the network and viscosity, as described previously in Chapter 1. Both flow rates and 
equivalent shear stress are representative of physiological conditions in skeletal muscle 
and cerebral circulation, since only one buffer was used (same viscosity), flow rate was 
preferred to present the data.  Arterioles diameter was recorded with LabScribe myogram 
software (version 4, iWorx Systems Inc., Dover, NH, USA), synchronized to a monitor & 
video dimension analyzer to track diameter changes. 
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Figure 3: EC50 Drug response curves - Arteriolar diameter response to higher drug 
concentrations to determine endothelial and vascular smooth muscle viability. 
Serotonin (5-HT) and Acetylcholine (Ach) for middle cerebral arterioles. Phenylephrine 
(Pe) and Acetylcholine (Ach) for Gracilis arterioles. 
2.2.2  Statistical Analysis 
Statistical analysis was performed in Prism (version 8.2.0, GraphPad Software Inc., La 
Jolla, CA, USA). Two-way ANOVA with Tukey’s multiple comparison test to determine 
significant differences between control and GSM treated groups at any given flow 
rate.  Moreover, student t-test was employed to determine significant differences between 
gender groups. To asses Piezo 1 role in the regulation of myogenic effect, Two-way 
ANOVA with Tukey’s multiple comparisons was applied to evaluate significance 
between component groups in myogenic challenges.  All values analyzed for flow and 
myogenic challenges were presented as mean ± SEM. 
50 
 
2.3 Results 
2.3.1  Grammostola Mechanotoxin 4 EC50 determination 
Initially, we determined to use Grammostola Mechanotoxin 4 (GSM/GsMTx4) as Piezo 1 
blocking agent due to previous studies reports that have shown more than 80% of Piezo 1 
mediated activating currents. To establish GSM effective concentration, we ran a small 
set of experiments to determine the concentration where the compound starts to induce its 
deleterious effect over the autoregulating mechanism. Increasing concentrations from 
GSM (10-10-10-6) were incubated in the superfusate or through the intraluminal PSS 
perfusion and run pressure and flow challenges to determine the EC50. As result, we 
obtained a GSM EC50 between 10-9-10-7. Previous pharmacological studies on this 
compound, done in our lab, on in-vivo gluteus maximus preparations reporter an EC50 
OF 10-7; thus, we deemed essential to use this concentration to assure proper Piezo 1 
proteins blockade. 
 
Figure 4: GSM EC50 normalized response curve. Arteriolar diameter changes to 
incremental GSM incubations done in gracilis arterioles. A. GSM superfusate incubation 
B. GSM intraluminal incubation.  
2.3.2 Piezo 1 effect over endothelial Flow-Induced Dilation  
Arteriolar diameters were recorded continuously at a rate of 100 samples/sec for ten 
minutes with LabScribe software. After all, values being exported, the individual 60,000 
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points in time were averaged on all conditions and normalized to weight to tease out the 
influence of the 150 mg difference between genders weight (Males: 414 gr., Females: 
264 gr.). 
 
Figure 5: Relationship between changes in arteriolar diameter and treatment 
conditions at different flow rate challenges for Middle cerebral arterioles (MCA). 
Data presented as percent change ± SEM (Males n= 29; Females n=22) (*,**,**** 
Significantly different from control condition at p < 0.0005). 
 
Figure 6: Relationship between changes in arteriolar diameter and treatment 
conditions at different flow rate challenges for Gracilis arterioles. Data presented as 
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percent change ± SEM (Males n= 29; Females n=22) (***,****Significantly different from 
control condition at p < 0.005). 
Arterioles exposed to Piezo1 antagonism were significantly different from control 
groups, and we can reject the null hypothesis since the significant overall main effect was 
observed on all harvested MCA vessels incubated with GSM(SF) & GSM(IL) in a 
completely different set of both harvested vessels. Since the overall response to GSM was 
a decrease in flow-induced dilation, with exception of Piezo1 antagonism in middle 
cerebral arterioles from female subjects, we were determined to validate if the apparent 
GSM interaction measured did not result of cross-reactivity to nitric oxide synthase. 
Thus, we used N-Nitroarginine methyl ester (L-name) from Sigma-Aldrich (Merck 
KGaA, Darmstadt, Germany), a known Nitric oxide synthase (NOS) inhibitor, by itself, 
plus in combination with GSM, and repeat flow challenges to tease out the effect of NOS 
blockade as the reason of the impaired vasodilation. Also, after the respective flow 
challenges with GSM, we added once again ACH to determine if the detriment 
vasodilating response, was due to a decrease in NO bioavailability. 
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Figure 7: Main effect of flow rate increases and its relationship to vasodilation at 
control conditions and after GsMTx4 (GSM) antagonism for Middle cerebral 
arterioles (MCA). A. Control conditions for Male (n=29) and Females (n=22). B. Main 
effect on arteriolar diameters after GSM intraluminal incubation, control condition is 
represented as baseline (BL) in dashed lines (Males n= 12; Females n=9). C. Main effect 
on arteriolar diameters after GSM superfusate incubation, control condition is represented 
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as baseline (BL) in dashed lines (Males n= 10; Females n=9). All data is presented as 
percent change ± SEM (* Significantly different from control condition at p < 0.05, #,### 
GSM response significantly different between genders at p < 0.005). 
 
Figure 8: Main effect of flow rate increases and its relationship to vasodilation at 
control conditions and after GsMTx4 (GSM) antagonism for Gracilis arterioles 
(GA). A. Control conditions for Male (n= 29) and Females (n=19). B. Main effect on 
arteriolar diameters after GSM intraluminal incubation, control condition is represented 
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as baseline (BL) in dashed lines (Males n= 14; Females n=10). C. Main effect on 
arteriolar diameters after GSM superfusate incubation, control condition is represented as 
baseline (BL) in dashed lines (Males n= 12; Females n=8). All data is presented as 
percent change ± SEM (### GSM response significantly different between genders at p < 
0.05). 
 After confirming that GSM antagonistic effect plays a significant negative role on shear 
dependent dilation regulation by Piezo 1, we replotted the same data as a relationship 
between flow rates and arteriolar diameter changes (Fig4 & Fig5) in order to understand 
if location of where the incubation takes place weights as a significant factor in the main 
effect interaction, as well as to determine sensitivity changes across the increasing flow 
rates. 
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2.3.3  Piezo 1 effect over Myogenic control 
 
Figure 9: Relationship between changes in arteriolar diameter and treatment 
conditions at increasing intralumenal pressure for Middle cerebral arterioles 
(MCA). Data presented as raw arteriolar diameter change ± SEM; Males n= 27, Females 
n= 24 (*,**** Significantly different from control condition, GSMIL Females = p < 0.013, 
GSMSF Males = p < 0.0001; #,## GSM response significantly different between genders, 
GSMIL at p < 0.03 & GSMSF at p < 0.0001). 
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Figure 10: Relationship between changes in arteriolar diameter and treatment 
conditions at increasing intraluminal pressure for Gracilis arterioles. Data presented 
as raw arteriolar diameter change ± SEM; Males n= 28, Females n= 22 (*,**,**** 
Significantly different from control condition, GSMIL Males = p < 0.0030, Females = p 
< 0.015; GSMSF Males = p < 0.0001, Females = p < 0.0029). 
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As we stated in the first chapter, myogenic constriction as a response to increasing 
intraluminal pressure (Fig6 and Fig7) play an indispensable role in homeostatic 
regulation. To test whether Piezo 1 activity significantly contributes to the mechanical 
sensitization of circumferential stress, thus triggering myogenic constriction, we tested 
the hypothesis that myogenic response in females will be markedly altered in skeletal 
muscle arterioles result of loss of active tone and loss in sensitivity to greater shifts of 
pressure and plotted as a relationship between  intraluminal pressure changes and 
arteriolar diameter. We found that after Piezo 1 antagonism there is a significant 
difference in myogenic control, were males and females present a significant loss of 
active tone after GSM incubation on both representatives of the peripheral circulation 
studied, with a particular significant contrast in the cerebral circulation. 
2.4 Discussion 
The purpose of this work was to determine for the first, to our knowledge, Piezo 1 impact 
in the transduction of forces and the role it plays in the regulation of myogenic response 
and shear-induced dilation. As well as, gender-based dimorphisms result of Piezo 1 
mechanosensitive effect. As we observe in Fig2 and Fig3., GSM antagonism on Piezo 1 
compromises dilation on both types of harvested vessels and its effect was independent of 
eNOS activity. Particularly and contrary to was expected, male data presented in Fig.2, 
show a greater detriment on flow-induced dilation. Nevertheless, we did observe the 
expected adverse effect after intraluminal incubation males across all the flow rates, 
presenting a decrease of 78.8% compared to superfusate incubation were the results of 
40.4% in a decrease of vasodilation response. Moreover, females presented a 28.5% 
decrease after superfusate incubation, but we were surprised to see that after intraluminal 
incubation instead of observing a decrease, results showed an increase of almost 2 times 
the dilation vascular response observed under baseline conditions. In contrast, GA data 
reported in fig.3 reports the expected effect after Piezo 1 antagonism, where both genders 
seemed to be significantly affected by GSM antagonism to Piezo1 channels but 
seemingly, females were affected in a higher magnitude, regardless of where incubation 
of GSM had taken place. After intraluminal incubation females, across all the flow rates, 
presented a dilation decrease of 55.6% compared to superfusate incubation were the 
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results were 55.5% decrease in vasodilation. As mentioned, males seemed to present a 
negative effect on shear-dependent dilation of lower magnitude with an 18.2% decrease 
after superfusate incubation and a 13.9% decrease in vasodilation after intraluminal 
incubation.  
To consider Piezo1 effect over sensitivity in MCAs & GAs Fig4 & Fig5 report that under 
control conditions females have significantly greater dilation response & greater 
sensitivity to flow rate changes compared to males. As shown in Fig. 4, after GsM 
incubation IL, we observed a proportional downward shift and decrease in sensitivity on 
males and females compared to control conditions(BL), where males presented a 
significant downward shift on the lower flow rates (5 ul/min & 10ul/min) and although 
females reflected greater compromise in sensitization on the higher flow rates did not 
shown significant differences mainly to greater variability on the data obtained at higher 
rates (30 ul/min & 60 ul/min). Contrarily, after GSM superfusate incubation both genders 
seemed to preserve flow shear sensing properties and present even present an upward 
shift in dilation magnitude, being females with a significantly greater magnitude 
compared to males.  
Figure5 shows Flow in GAs, where the persistence of female significantly greater 
response and greater sensitivity to flow rate changes compared to males were still 
observed in skeletal muscle arterioles. Regardless of GsMTx4 incubation, we reported 
the preservation in sensitivity among both genders, as well as the significant greater 
magnitude in females flow-dependent dilation response as seen under control conditions. 
At physiological intraluminal pressures myogenic response in MCAs (Fig6) we were not 
able to report any differential response between genders at baseline conditions (BL). 
Nonetheless, when Piezo1 antagonist GSM was incubated IL, females reported a 
significant loss of 40% of active tone compared to baseline, but not in males. Although 
males had a similar shift of 33.3% in arteriolar diameter compared to baseline conditions 
it was not significantly different to control conditions (BL). After superstate incubation of 
GSM males, compared to females, had a compromised myogenic response by active tone 
loss of 39.8%, significantly different from its control state. Although females had a 
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similar shift of 22.8% in response to Piezo1 antagonism it was not significant. 
Furthermore, regardless of the incubation type, the differential effects after Piezo 1 
antagonism were significantly different between genders. 
In contrast to cerebral circulation, impairment of the myogenic response in GAs after 
Piezo1 antagonism did not show gender dimorphism in spite of the differential GSM 
applications. Though, we were able to report a significant loss in myogenic response with 
an overall effect versus control conditions result from a loss of active tone of 41.5% and 
40.8% in males and females respectively. 
2.5 Limitations 
Although, we choose to employ isolated preparations in our experimental protocol to 
precisely control most of the experimental conditions (luminal pressure, shear stress, 
superfusate & perfusate solutions, etc.) and elucidate phenotypical variances, as well as 
gender-based dimorphisms in this project, as we deemed to be a better fitting model. One 
of the main disadvantages derived from ex-vivo preparations come from the loss of other 
regulating mechanisms constantly counterbalancing (neuro-humoral, metabolic and 
intercellular conduction input) (16,17) and one of the main problems in this matter we 
encountered in our flow challenges, as previously discussed. 
Moreover, flow rates employed in our experimental protocol were selected as a result of 
initial flow response curves to determine the capacity of the experimental operating 
systems to autoregulate intraluminal pressure as a response to increases in flow rates. 
Although, the chosen flow rates concur within the physiological intraluminal pressures 
observed on in-vivo gluteus maximus preparations and modeling techniques from 
previous studies from our lab (18), there is a concern that 30 ul/min & 60 ul/min rates are 
three to six orders of magnitude above the physiological ranges expected in vessels of the 
same order (18). Nonetheless, the literature has reported different ranges correspondingly 
to the area where the vessels for the ex-vivo preparations were harvested and established 
a three times value deviation between experimental and in vivo values, due to viscosity 
differences between blood and saline solution (4).Thus, the effects of the higher flow 
rates shall be carefully considered as representatives of a hemodynamic state where the 
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flow rate is at maximum functional capacity and serve as a threshold limit for posterior 
projects. 
2.6 Conclusion  
As stated in the first chapter, gender-based dimorphisms and differential effects in local 
regulation mechanisms were expected in cerebral and musculoskeletal circulations. When 
compared versus males, female middle cerebral vessels tend to preserve better shear-
induced dilation after Piezo1 mechanosensitive properties were blocked with GSM, 
except for direct Piezo1 antagonism in the endothelium, where higher flow rates were 
greatly compromised and sensitivity to higher flow rates approach male control values. 
Although this effect was not significant, linear regression analysis resulted in a negative 
trend (Y = -0.001158*X + 0.4506) and most likely by getting closer to a balanced sample 
size of n=15, significance on the interaction will be present. As expected, male and 
female musculoskeletal arterioles seemingly preserve flow better regardless of Piezo1 
antagonism directly in the endothelium or in smooth muscle cells, but still, we were able 
to elucidate Piezo1 in ECs as a determinant for shear load sensitivity.  
Piezo1 properties to bellwether pressure loads in SMC, were more visible in males 
compared to females especially on cerebral arterioles, knowingly more dependent on 
sensing pressure variations to protect encephalic tissue. GAs was overall affected by 
GSM antagonism over Piezo 1 channels but regardless of GsMTx4 incubation (SF or IL) 
loss of pressure sensing related to Piezo1 was still observed on musculoskeletal 
vasculature. 
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Chapter 3  
 
General Discussion
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3.1. Contributions 
The main purpose of this graduate thesis serves as a first approach to understand Piezo 1 
as a fundamental piece of “the puzzle” that is understanding homeostatic regulation in the 
microvascular networks. Furthermore, for the first time, we approach Piezo 1 
mechanosensitive properties from a more comprehensive approach to its differential 
effects in both cell lines that encompass the vasculature and the way the impact local 
regulating mechanisms, in particular, myogenic constriction & shear-induced dilation. 
In addition, we explored for the first time Piezo 1 interactions and differential effects on 
resistance arterioles from skeletal muscle and cerebral circulation, which we have  
addressed previously in the first chapter of this dissertation, have been prominently 
reported to address their local regulation in specific ways that correlate to their 
physiological needs (39,61,62,127). Although functional approaches to determine Piezo1 
impact in myogenic control and flow-induced vasodilation have been reported previously 
(111,127,134), these research groups have appeal  to understand the role of Piezo 1 just in 
the context of the functional detriment to the regulating mechanisms in vessels from 
Piezo knockout subjects and didn’t considered gender dimorphisms in their studies. 
Having a preference for ex-vivo isolated vessel techniques besides from their practical 
benefit to control, detailed out in the first chapter (sec.1b), we were able to select and test 
under specific physiological scenarios in a heterogeneous group model with diverse 
gender, arterioles, and mechanisms of incubations. With this model, we were able to 
report about the indispensable role Piezo1 mechanotransduction properties plays into 
regulation of myogenic control and shear-induced dilation, as well as report for the first 
time male and female differences dependence to this mechanosenstive ion channel in 
different circulatory systems.  
Nonetheless, as a secondary and more global purpose, this thesis serves as an attempt at 
our lab to keep working in understanding and develop tools that help bring clarity in an 
understudied area of research that is cardiovascular research and moreover, gender 
differences. By approaching Piezo1 mechanotransduction properties contemplating 
gender dimorphisms and anatomical differences, opens a field of Piezo 1 proteins as 
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potential biomarkers or target therapies providing a more effective treatments for 
cardiovascular diseases in males and females.  
Piezo 1 potential as prognostic & predictive biomarker is exemplified by its recently 
established relationship to cell migration, a defining characteristic of highly metastatic 
cancer cells. MCF-7, a highly malignant breast cancer cell line identified with higher 
Piezo 1 concentrations or PC-3, associated to a highly aggressive form of prostate cancer, 
mechanical activated currents can be blocked by GsMTx4 (8,9). Furthermore, biomarker 
and treatment possibilities can be exemplified by recent reports on MicroRNA-103a, 
which directly targets and regulates Piezo1 gene expression. MicroRNA-103a, has been 
associated with biomarker qualities for CVD’s as Hypertension or Acute myocardial 
infarction and as etiological factor for Hypertension. Nonetheless, further studies are 
needed to clarify the role of miR-103a and Piezo1. As other MicroRNA’s, miR-103a can 
target multiple genes, but it is still unknown how many of these genes are involved in 
regulatory effects on the biological functions of endothelial cells (7).  
3.2. Future work 
Although, we tried to quantify Piezo 1 concentrations in different homogenates from the 
same vascular tissues employed in our pressure and flow challenges, as well as in other 
conduit vessels (renal artery, Iliac artery, abdominal & thoracic aorta), lung tissue and 
gluteus maximus tissue, excised from the same males and females. We were not able to 
collect enough tissue to run consistent Piezo 1 protein quantifications in MCA & GA, due 
to the need for greater dilution ratios or small volumes of microvessel homogenates. 
Nonetheless, we are aware that the effects found in our experiments can be the result of 
quantifiable differences in the gender and microvessels selected for this project. 
Thus, as next step we are aware that smaller volumes, though more concentrated 
homogenates, would require the use of Piezo 1 Enzyme-Linked Immunosorbent Assay 
(ELISA) kits to finally confirm if the deleterious effects reported in our result section are 
result of a heterogenous presentation of Piezo 1 proteins in the vasculature of cerebral 
and skeletal muscle circulation. Also we will repeat the ELISA with enzyme digested cell 
cultures of VSMCs and ECs, to quantify Piezo1 differences in the membranes of the 
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individual cellular components of the vasculature, which will enrich our understanding of 
the role Piezo 1 plays as a determinant factor not only in regulating mechanisms of the 
microcirculation but as well as in other conduit vessels and vascular systems. 
Furthermore, we will thrive to analyze and increase the sample size for our IVVM 
experiments to have a better perspective on the in-vivo factors that impact the overall 
regulation of the microvasculature and functional relevance to Piezo1 blockade. As 
previously mentioned in chapter 2 of this dissertation, shear stress variations found 
between ex-vivo and in-vivo models influence the way we may interpret endothelial 
responses to shear stress, considering viscosity disparity due to the perfusate solution in 
ex vivo preparations and contemplate the interaction with other regulating mechanism in 
order to understand better the negative effects of Piezo1 antagonism. It is important to 
note that it will take three times the volume flow with saline to elicit the same endothelial 
shear stress responses with ex-vivo preparation, compared to in-vivo experimental 
models as IVVM, due to viscosity differences between blood and saline perfusate. 
Additionally, loss of regulating mechanisms in ex-vivo models, but found in-vivo, like 
neuro-humoral, metabolic or intercellular conduction, make IVVM the next best step to 
further explore Piezo 1 phenotypical variances under physiological and pathological 
conditions. 
Finally, we will develop model studies with endothelial-specific and SMC specific 
knockout mice. With our current approach was impossible to determine phenotypical 
differences. Piezo1 gain of function or loss of function variations have not been 
correlated to differences between gender and harvested vessels, nor if the phenotypical 
variations play a role in the incidence of pathologies mentioned thought this dissertation. 
Although the specific endothelial knockout is lethal, we will work around this condition 
with tamoxifen conditional knockouts for the endothelial variable. 
Our project is part of continuous effort in our lab for over a decade to understand and 
develop tools & techniques that help bring clarity in an underfunded area, that is 
cardiovascular research and the role sex differences play in autoregulation of the 
microvasculature. Therefore, we will work to add Piezo 1 mechanosensitive properties in 
68 
 
our computational models to properly predict their outcome in control conditions and 
conditions such as hypertensive, X syndrome and diabetic, where Piezo 1 reports have 
shown significant effects as marker or treatment targets. 
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List of abbreviations and Symbols 
SD: Sprague Dawley 
MCA: Middle Cerebral Arteriole 
GA: Gracilis Arteriole 
GsMTx4 or GSM: Grammostola Mechanotoxin 4 
EC: Endothelial Cells 
VSMC: Vascular Smooth Muscle Cells 
SAC: Stretch-activated ion Channels  
Ca++: Calcium 
 eNOS: Endothelial Nitric Oxide Synthase 
iNOS: Inducible Nitric Oxide Synthase 
NO: Nitric Oxide 
CVD: Cardiovascular Disease 
ERα: Estrogen Receptors α 
ERβ: Estrogen Receptors β 
MAP: Mitogen Activated Protein 
MSNA: Sympathetic Nerve Activity to Skeletal Muscle  
NPY: Neuropeptide Y  
NA: Noradrenaline  
Y1R: Neuropeptide Y Type 1 Receptor 
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α1R: Adrenergic α1 Receptor 
BP: Blood Pressure  
VC: Vascular Conductance 
HERS: Heart Estrogen/Progestin Replacement Study  
CHD: Coronary Heart Disease  
CBF: Cerebral Blood Flow 
cGMP: Cyclic Guanosine Monophosphate 
PGH2: Prostaglandin H2  
OVX: Ovariectomized  
OVE: Estrogen Replacement 
WSS: wall shear stress 
τ:  Shear stress 
η: Viscosity of fluid 
Q: Flow rate 
π: Pi 
r: Radius of tube 
PGI2: Prostaglandin I2  
EDHF: Endothelium-dependent Hyperpolarizing Factor  
K+: Potassium 
TGFb: Transforming growth factor beta 
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Na+: Sodium 
FAM38a: Piezo 1  
DRG: Dorsal Root Ganglion Neurons  
MS or MSC: Mechanosensitive Ion Channels  
ECM: Extracellular Matrix 
HUVEC: Human Umbilical Vein Endothelial Cells 
ExAC: Exome Aggregation Consortium 
SNA: Sympathetic Nervous Activity 
HR: Heart Rate 
FlnA: Filamin A 
TRP: Transient receptor potential channel 
K2p: Two pore domain potassium channels 
TREK-1: Potassium channel subfamily K member 2 
TRAAK: Potassium channel subfamily K member 4 
NOMPC: No Machanoreceptor Potential C 
IP: Intraperitoneal injection 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid Buffer 
5-HT: Serotonin   
Ach: Acetylcholine  
Pe: Phenylephrine  
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GSM(SF): Grammostola Mechanotoxin 4 incubated in the superfusate 
GSM(IL): Grammostola Mechanotoxin 4 incubated intraluminal 
BL: Baseline  
SEM: Standard Error of the Mean 
ELISA: Enzyme-Linked Immunosorbent Assay 
IVVM: Intravital Video-Microscopy 
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